Neuroprotection in Stroke-Focus on the Renin-Angiotensin System: A Systematic Review.
neuroprotection
renin-angiotensin
stroke
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
31 Mar 2022
31 Mar 2022
Historique:
received:
18
02
2022
revised:
25
03
2022
accepted:
29
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
14
4
2022
Statut:
epublish
Résumé
Stroke is the primary cause of disability in the adult population. Hypertension represents the leading risk factor being present in almost half the patients. The renin-angiotensin system is involved in the physiopathology of stroke and has an essential impact on hypertension as a risk factor. This article targeted the role of the renin-angiotensin system in stroke neuroprotection by reviewing the current literature available. The mechanism of action of the renin-angiotensin system was observed through the effects on AT1, AT2, and Mas receptors. The neuroprotective properties ascertained by angiotensin in stroke seem to be independent of the blood pressure reduction mechanism, and include neuroregeneration, angiogenesis, and increased neuronal resistance to hypoxia. The future relationship of stroke and the renin-angiotensin system is full of possibilities, as new agonist molecules emerge as potential candidates to restrict the impairment caused by stroke.
Identifiants
pubmed: 35409237
pii: ijms23073876
doi: 10.3390/ijms23073876
pmc: PMC8998496
pii:
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Références
Stroke. 2002 Mar;33(3):862-75
pubmed: 11872916
Am J Hypertens. 2014 Aug;27(8):1036-44
pubmed: 24572705
Am J Cardiovasc Drugs. 2007;7(1):25-37
pubmed: 17355164
Stroke. 2007 May;38(5):1655-711
pubmed: 17431204
Cerebrovasc Dis. 2004;18(4):304-11
pubmed: 15331877
Neurology. 2006 Apr 25;66(8):1153-8; discussion 1135
pubmed: 16636230
Stroke. 1999 Nov;30(11):2391-8; discussion 2398-9
pubmed: 10548676
Expert Rev Hematol. 2016 Sep;9(9):891-901
pubmed: 27367035
Eur J Pharmacol. 2014 Feb 5;724:9-15
pubmed: 24361310
Circulation. 2000 Oct 24;102(17):2087-93
pubmed: 11044425
Lancet. 2011 Feb 26;377(9767):741-50
pubmed: 21316752
Neurol Sci. 2008 Sep;29 Suppl 2:S277-8
pubmed: 18690518
Lancet. 2020 Mar 14;395(10227):878-887
pubmed: 32087818
J Immunol. 2010 Nov 1;185(9):5569-76
pubmed: 20935211
Heart Fail Rev. 2008 Sep;13(3):321-37
pubmed: 17990104
J Hypertens Suppl. 2006 Mar;24(1):S115-21
pubmed: 16601564
Biochem Biophys Res Commun. 2013 Jan 11;430(2):642-6
pubmed: 23219836
Am J Cardiovasc Drugs. 2005;5(4):245-53
pubmed: 15984907
FASEB J. 2003 Nov;17(14):2094-6
pubmed: 14500552
Neuropharmacology. 2014 Jun;81:134-41
pubmed: 24508710
FASEB J. 2005 Apr;19(6):617-9
pubmed: 15665034
Regul Pept. 2003 Feb 28;110(3):241-7
pubmed: 12573806
Neuropharmacology. 2013 Aug;71:154-63
pubmed: 23583926
Curr Hypertens Rep. 2012 Jun;14(3):202-8
pubmed: 22447068
Circulation. 2020 Aug 4;142(5):426-428
pubmed: 32213097
Stroke. 2003 Jan;34(1):214-23
pubmed: 12511777
J Cereb Blood Flow Metab. 2019 Aug;39(8):1635-1647
pubmed: 29537907
Curr Atheroscler Rep. 2011 Aug;13(4):298-305
pubmed: 21626308
Lancet. 2002 Mar 23;359(9311):995-1003
pubmed: 11937178
Exp Transl Stroke Med. 2016 Oct 7;8:8
pubmed: 27761230
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
Br J Pharmacol. 2011 Jul;163(6):1122-30
pubmed: 21175580
Hypertension. 2008 Dec;52(6):1120-6
pubmed: 18852384
Stroke. 1986 Jan-Feb;17(1):82-5
pubmed: 3945989
Lancet Neurol. 2016 Aug;15(9):913-924
pubmed: 27291521
Endocr Rev. 1992 May;13(2):329-80
pubmed: 1618166
Circulation. 2004 Aug 17;110(7):843-8
pubmed: 15289370
Stroke. 1994 Jul;25(7):1476-9; discussion 1480
pubmed: 8023365
Curr Atheroscler Rep. 2001 Mar;3(2):117-24
pubmed: 11177655
J Pharmacol Exp Ther. 2013 Feb;344(2):348-59
pubmed: 23211364
Stroke. 2009 Apr;40(4):1482-9
pubmed: 19246705
Med Biol Eng Comput. 2008 May;46(5):461-7
pubmed: 18228071
Transl Stroke Res. 2020 Aug;11(4):762-775
pubmed: 31792796
Curr Pharm Des. 2005;11(25):3275-91
pubmed: 16250855
Stroke. 2000 Oct;31(10):2478-86
pubmed: 11022082
FASEB J. 2002 Feb;16(2):169-76
pubmed: 11818364
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Clin Neurol Neurosurg. 2009 Jul;111(6):483-95
pubmed: 19446389
BMC Neurol. 2005 Jun 10;5(1):10
pubmed: 15949043
Hypertension. 2012 Dec;60(6):1531-7
pubmed: 23090772
BMJ. 2020 Feb 13;368:l6983
pubmed: 32054610
Exp Physiol. 2014 Feb;99(2):442-53
pubmed: 24142453
Peptides. 2005 Aug;26(8):1401-9
pubmed: 16042980
J Cereb Blood Flow Metab. 1995 May;15(3):378-84
pubmed: 7536197
Stroke. 2009 Dec;40(12):3876-8
pubmed: 19892999
J Cereb Blood Flow Metab. 2004 May;24(5):536-47
pubmed: 15129186
Hypertension. 2005 Aug;46(2):386-92
pubmed: 16009786
Lancet. 2012 Jul 28;380(9839):349-57
pubmed: 22691567
J Cardiovasc Pharmacol. 1994 Dec;24(6):937-40
pubmed: 7898077
J Mol Med (Berl). 2016 Aug;94(8):957-66
pubmed: 26983606
J Clin Hypertens (Greenwich). 2007 Jun;9(6):454-9
pubmed: 17541331
Stroke. 1995 Aug;26(8):1329-33
pubmed: 7631331
Exp Physiol. 2011 Oct;96(10):1084-96
pubmed: 21685445
PLoS One. 2014 Apr 21;9(4):e95762
pubmed: 24752645
Stroke. 2006 May;37(5):1271-6
pubmed: 16601219
J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):495-505
pubmed: 24622157
Exp Physiol. 2018 Jun;103(6):916-923
pubmed: 29663576
Hypertension. 2009 Oct;54(4):782-7
pubmed: 19635982
J Hypertens. 2008 Mar;26(3):544-52
pubmed: 18300867
Blood Press. 2001;10(5-6):344-51
pubmed: 11822538
Stroke. 2005 Jun;36(6):1218-26
pubmed: 15879332
Regul Pept. 1998 Nov 30;78(1-3):1-11
pubmed: 9879741
Clin Sci (Lond). 2014 Feb;126(3):195-205
pubmed: 24102099
J Cereb Blood Flow Metab. 2004 Apr;24(4):467-74
pubmed: 15087716